Zydus Lifesciences received an Establishment Inspection Report (EIR) from the USFDA for its Ahmedabad facility. Shares rose nearly 1%, reflecting investor confidence despite past regulatory issues.
Zydus Lifesciences received an Establishment Inspection Report (EIR) from the USFDA for its Ahmedabad facility. Shares rose nearly 1%, reflecting investor confidence despite past regulatory issues.